Amyloid beta deposition in the brain is the hallmark of Alzheimers disease. Co-deposition of other amyloidogenic proteins like transthyretin, human cystatin C have been found in the plaques along with A beta. Revealing the details of the interaction between these proteins with A beta peptide in vitro is able to provide insight into finding new therapies for the disease.